Revista Espanola de Quimioterapia

Papers
(The H4-Index of Revista Espanola de Quimioterapia is 16. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
COVID-19 in donation and transplant71
39
36
Systemic absorption of liposomal inhaled amikacin in the treatment of resistant Mycobacterium avium: beyond expectations31
Successful rezafungin treatment of an azole-resistant Candida parapsilosis vascular graft infection30
Invasive group A Streptococcus infection (Streptococcus pyogenes): Current situation in Spain26
Application of CMO (capacity, motivation, and opportunity) methodology in pharmaceutical care to optimize the pharmacotherapy in older people living with HIV. DISPIMDINAC project26
Highlights in HIV 2022-202426
De la rinolicuorrea al 16S: meningitis por Streptococcus salivarius26
Evaluation of two immunocromatographic tests for the detection of antibodies against SARS-CoV-223
Interactions listed in the Paxlovid fact sheet, classified according to risks, pharmacological groups, and consequences20
Influence of epidemiological and clinical factors in the reactogenicity to Comirnaty® vaccine in health care workers of a Spanish university teaching hospital (COVIVAC study)19
Is Propionimicrobium lymphophilum a new urinary tract infection cause?19
The importance of prevalence and pre-test probability on the microbiological diagnosis of SARS-CoV-2: the case of Spain in 202018
18
Generalized lynphadenopathy and disseminated Mycobacterium lentiflavum infection in an immunosuppressed patient17
Temporal evolution of antiretroviral therapy (2017-2021): analysis of treatment change and its economic impact16
0.094550132751465